109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases
#4502PLASMIDS COMPRISING INTERNAL RIBOSOMAL ENTRY SITES AND USES THEREOF
#4503Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#4504HER3 Inhibition in Low-grade Serous Ovarian Cancers
#4505ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#4506FSH nucleic acid molecules to control insect pests
#4507Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#4508BIOLOGICAL CONTROLS OF COLEOPTERAN PESTS
#4509Compositions and methods for diagnosis and treatment of prostate cancer
#4510KRAS nucleic acids and uses thereof
#4511RNA interference compositions targeting heat shock protein 90 and methods of use thereof
#4512DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS
#4513Therapeutic compositions
#4514Blocking monoclonal antibodies to AGR2 and its receptor C4.4A
#4515Compositions and methods for treating and preventing inflammation
#4516Programmable polypeptide and nucleic acid nanoparticles
#4517NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#4518Molecular targets for the treatment of wounds, in particular chronic wounds
#4519Methods and compositions for the treatment of cancer
#4520Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent
#4521Modified double-stranded RNA agents
#4522Cancer treatment and immune system regulation through FAT10 pathway inhibition
#4523Chiral control
#4524Compositions and methods for treating vascular disorders
#4525METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF MYC BY DOUBLE-STRANDED RNA
#4526Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1
#4527Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles
#4528Methods for identifying and treating invasive/metastatic breast cancers
#4529Method and treatment of recurring endometrial cancer with an inhibitor of USP14
#4530Methods and compositions for preventing or reducing infections of crop plants by bacterial and fungal pathogens
#4531DIAGNOSTIC AND THERAPEUTIC TARGETING OF DNMT-1 ASSOCIATED RNA IN HUMAN CANCER
#4532COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#4533Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#4534Approach for treatment of cancer via immunomodulation by using talabostat
#4535Compositions for modulating cancer stem cells and uses therefor
#4536Methods for sub-typing and treating cancer
#4537Next generation RNA-sequencing and long non-coding RNA in glioblastoma multiforme
#4538MUCOSAL HEALING PROMOTER
#4539Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity
#4540POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#4541Delivery of dsRNA to arthropods
#4542Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
#4543Methods of treating, inhibiting and/or preventing an auditory impairment
#4544NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#4545Compositions and methods for controlling insect pests
#4546Exosome transfer of nucleic acids to cells
#4547Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same
#4548Method for determining the repair activity of non-homologous end joining
#4549COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#4550Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers
#4551COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#4552APTAMER-RNAi THERAPEUTIC COMPOSITIONS
#4553Targeting ligands for therapeutic compounds
#4554COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#4555Polypeptide inhibitors of Smad3 polypeptide activities
#4556NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE
#4557Method of predicting obesity comprising measuring neurotensin
#4558ANTI-CANCER AGENT SENSITIVITY-DETERMINING MARKER
#4559Methods and compositions for root knot nematode control
#4560Interfering RNA molecules
#4561CDC25A inhibitor for the treatment of drug resistant cancer or for the prevention of tumor relapse
#4562NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI
#4563NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI
#4564Interfering RNA molecules
#4565Interfering RNA molecules
#4566MICRORNA WITH PLACENTA-PERMEABILITY AND USES THEREOF
#4567COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
#4568Interfering RNA molecules
#4569Polyol-based osmotic polydixylitol polymer gene transporter and use thereof
#4570MAP3K8 AS A MARKER FOR SELECTING A PATIENT AFFECTED WITH AN OVARIAN CANCER FOR A TREATMENT WITH A MEK INHIBITOR
#4571PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715
#4572Methods and Materials for Producing Coreless Fruit
#4573IMPAIRED WOUND HEALING COMPOSITION AND TREATMENTS
#4574Modulation of breast cancer growth by modulation of XBP1 activity
#4575Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells
#4576NUCLEIC ACIDS, AND USES THEROF
#4577Multiplexed shRNAs and uses thereof
#4578GNAQ targeted dsRNA compositions and methods for inhibiting expression
#4579DNA-RNA hybrid particles and manufacturing method thereof
#4580VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVES
#4581Compositions and methods for enhancing cardiac function in the neonate
#4582Antibody-siRNA conjugates and uses therefor
#4583Small molecule inhibitors of RNA binding motif (RBM) proteins for the treatment of acute cellular injury
#4584BIOLOGICALLY ACTIVE NUCLEOTIDE MOLECULES FOR SELECTIVELY KILLING OFF CELLS, USE THEREOF, AND APPLICATION KIT
#4585UREIDOPYRIMIDONE SUPRAMOLECULAR COMPLEXES FOR COMPOUND DELIVERY INTO CELLS
#4586Compositions for controlling mites in bees
#4587Compositions Comprising Small Interfering RNA Molecules for Prevention and Treatment of Ebola Virus Disease
#4588Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat
#4589NUCLEIC ACID LIPID PARTICLE FORMULATIONS
#4590Twist signaling inhibitor compositions and methods of using the same
#4591Tetragalnac containing conjugates and methods for delivery of oligonucleotides
#4592POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF
#4593Breast Tumor Markers And Methods Of Use Thereof
#4594DETECTION OF VIRAL INFECTION
#4595INHIBITORY RNA FOR ENHANCED PROTEIN PRODUCTION IN RECOMBINANT MAMMALIAN CELLS
#4596PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
#4597METHODS OF TREATING ISCHEMIA-REPERFUSION INJURY WITH siRNAS
#4598TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#4599PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS
#4600Nucleic acid aptamers
#4601Method for improving memory using CCNY inhibitor
#4602Cationic lipid
#4603Screening method
#4604PANCREATIC CANCER TARGETS AND USES THEREOF
#4605GAWKY (GW) NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#4606RPB7 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#4607Methods for preparing pecific polypeptide-binding antibodies
#4608Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
#4609Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB
#4610Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
#4611METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47
#4612OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY
#4613DELIVERY MOLECULES FOR THERAPEUTICS
#4614Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
#4615Administration of FGF9 for treatment and prevention of major depression
#4616Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cells
#4617Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#4618Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
#4619ENHANCED REPROGRAMMING TO IPS CELLS
#4620Honey bee mite disruptive compounds and methods of application
#4621BARD1 isoforms in lung and colorectal cancer and use thereof
#4622USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER
#4623METHODS FOR OPTIMIZING ELECTROPORATION
#4624MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions
#4625dsRNA for treating viral infection
#4626Methods and compositions for treating insects
#4627Compositions for Targeted Delivery of siRNA
#4628Method for secretion of extracellular vesicles from cells and tissues using shock wave
#4629Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
#4630SYNTHESIS AND USE OF AMINO LIPIDS
#4631Aminoalcohol lipidoids and uses thereof
#4632Methods of inhibiting cancer stem cells with HMGA1 inhibitors
#4633R2R1/2 in diagnosis and therapy
#4634ENGINEERING MAMMALIAN GENOME USING DNA-GUIDED ARGONAUTE INTERFERENCE SYSTEMS (DAIS)
#4635Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease
#4636RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#4637Preventive or therapeutic agent for fibrosis
#4638Methods and Compositions for Modulating Lung Cancer Tumor Initiating Cells (TIC), and Oxytocin Receptor (OXTR) Modulatory Agents for Use in Practicing the Same
#4639COMPOSITION FOR TREATING CANCER ASSOCIATED WITH HPV INFECTION
#4640Diagnostic and therapeutic tool for cancer
#4641Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases
#4642Cationic lipid
#4643Lung cancer adjuvant therapy
#4644Method of encapsulating a nucleic acid in a lipid nanoparticle host
#4645Biomarkers for human monocyte myeloid-derived suppresor cells
#4646Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
#4647Solid Phase Transfection of Proteins and Nucleic Acids
#4648COMPOSITIONS AND METHODS OF USING SAME FOR INCREASING RESISTANCE OF INFECTED MOSQUITOES
#4649Targeting the steroidogenic pathway for treating and/or preventing allergic diseases
#4650PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS
#4651RNA EDITING BIOMARKERS FOR DIAGNOSIS, PHARMACOLOGICAL SCREENING AND PROGNOSTICATION IN CANCER
#4652Angiotensinogen (AGT) iRNA compositions and methods of use thereof
#4653USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#4654Bruton's tyrosine kinase as anti-cancer drug target
#4655Exosomal loading using hydrophobically modified oligonucleotides
#4656Compositions and methods for controlling insect pests
#4657Methods and compositions for treating neuropathic pain
#4658Polynucleotide agents targeting complement component C5 and methods of use thereof
#4659Use of miR-199a-5p, targets and/or inhibitors thereof for the diagnosis, prognosis and treatment of fibroproliferative disorders
#4660Method of separating senescent cells using overexpression of protocadherin
#4661Composition including pint gene expression inhibitor or pint activity inhibitor and use thereof
#4662LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY
#4663Composition for delivery of genetic material
#4664METHODS OF TREATING MITOCHONDRIAL DYSFUNCTION
#4665Retroviral vector having immune-stimulating activity
#4666COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LEPIDOPTERA
#4667Ribosomal protein L40 (RPL40) nucleic acid molecules that confer resistance to coleopteran and hemipteran pests
#4668Methods of treating cancer
#4669Exon skipping technology in VCP disease
#4670Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury
#4671INDIVIDUALIZED CANCER THERAPY
#4672Methods of controlling cell fate and consequences for disease
#4673Lepidopteran moth control using double-stranded RNA constructs
#4674Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer
#4675Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
#4676Methods for modulating Ataxin 2 expression
#4677Skin Permeating and Cell Entering (SPACE) Peptides and Methods of Use Thereof
#4678Drug delivery particle and method for producing the same
#4679LONG NON-CODING RNA AS A DIAGNOSTIC AND THERAPEUTIC AGENT
#4680METHOD FOR OPENING TIGHT JUNCTIONS
#4681siRNA structures for high activity and reduced off target
#4682COMPOSITIONS AND METHODS FOR TARGETING O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE AND PROMOTING WOUND HEALING
#4683Treatment of Liver Cancer through Embolization Depot Delivery of BORIS Gene Silencing Agents
#4684Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4685Methods for the treatment of cardiovascular fibrosis
#4686METHODS OF TREATING A METABOLIC SYNDROME BY MODULATING HEAT SHOCK PROTEIN (HSP) 90-BETA
#4687Methods and compositions for treating malignant tumors associated with kras mutation
#4688COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES
#4689COMPOSITIONS AND METHODS FOR MODULATION OF RORGAMMAT FUNCTIONS
#4690Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#4691Methods and compositions for treating a Serpinc1-associated disorder
#4692Small interfering RNA and pharmaceutical composition and method for inhibiting galectin-12 expression and/or enhancing lipolysis containing the same
#4693Medical devices for delivery of siRNA
#4694Modified natural killer cells and natural killer cell lines having increased cytotoxicity
#4695Methods of treating fragile X syndrome and related disorders
#4696Composition, kit, and method for diagnosing and treating ovarian cancer
#4697Method of producing lipid nanoparticles for drug delivery
#4698Methods for triggering de novo formation of heterochromatin and or epigenetic silencing with small RNAS
#4699Modulation of BCL11A for treatment of hemoglobinopathies
#4700Nanoparticle type oligonucleotide structure having high efficiency and method for preparing same
#4701LIPID PARTICLES WITH CATIONIC LIPIDS FOR RNA DELIVERY
#4702Cell lines for virus production and methods of use
#4703Ship inhibition to induce activation of natural killer cells
#4704METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#4705Use of compounds inhibiting apelin / APJ / GP130 signaling for treating cancer
#4706Multicistronic expression constructs
#4707Modular construction of synthetic gene circuits in mammalian cells using TALE transcriptional repressors
#4708Use of Mcoln-1 modulators to regulate cell migration
#4709Double stranded RNA constructs for aphid control
#4710METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#4711Combination of Anti-Clusterin Oligonucleotide with HSP90 Inhibitor for the Treatment of Prostate Cancer
#4712Transferrin/transferrin receptor-mediated siRNA delivery
#4713Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN
#4714Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#4715Ionizable cationic lipid for RNA delivery
#4716METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#4717Pharmaceutical composition for preventing or treating neurodegenerative diseases
#4718Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
#4719NANOCOMPOSITES OF GOLD AND POLYMERS
#4720LIPID FORMULATION
#4721Double strand RNA-mediated RNA interference through feeding detrimental to larval (gypsy moth)
#4722Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
#4723Compositions and methods for inhibiting expression of RRM2 genes
#4724Apoptosis inducer
#4725NEW TREATMENT AGAINST INFLUENZA VIRUS
#4726Inhibition of PCSK9 through RNAI
#4727MOLECULES AND AGENTS FOR TREATING HEPATITIS B VIRUS
#4728NOVEL SINGLE CHEMICAL ENTITIES AND METHODS FOR DELIVERY OF OLIGONUCLEOTIDES
#4729Organic compositions to treat APOC3-related diseases
#4730Nucleic acid functionalized nanoparticles for therapeutic applications
#4731IMPROVED SMALL INTERFERING RIBONUCLEIC ACID MOLECULES
#4732Amine cationic lipids and uses thereof
#4733Pharmaceutical composition and uses thereof
#4734Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer
#4735METHODS, ASSAYS, AND SYSTEMS RELATING TO SAKT
#4736Trans-acting elements for intracellular delivery of nucleic acid sequences
#4737SHIBIRE/DYNAMIN NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN AND HEMIPTERAN PESTS
#4738Methods for immortalization of epithelial cells
#4739Double-stranded oligo RNA targeted to amphiregulin and pharmaceutical composition comprising same for preventing or treating fibrosis or respiratory diseases
#4740Methods of using PVT1 exon 9 to diagnose and treat prostate cancer
#4741Compositions and methods to activate or inhibit toll-like receptor signaling
#4742Modified oligonucleotides for telomerase inhibition
#4743Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer
#4744Small molecules that enhance the activity of oligonucleotides
#4745Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
#4746Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
#4747METHOD FOR PREPARING RECOMBINANT GLYCOPROTEIN HAVING HIGH SIALIC ACID CONTENT, THROUGH GLYCOSPHINGOLIPID SYNTHESIS CYCLE CONTROL
#4748Peptide sequence design and use thereof for peptide-mediated siRNA delivery
#4749SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT
#4750Liposomal formulations for delivery of nucleic acids
#4751Algal mutants with increased lipid productivity
#4752METHOD FOR PRODUCING LIPID PARTICLES AND NUCLEIC ACID DELIVERY CARRIER HAVING LIPID PARTICLES
#4753NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
#4754Multifunctional RNA nanoparticles and methods of use
#4755Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves
#4756Inhibitors of metastasis
#4757Peptide, complex of peptide and siRNA and use thereof
#4758Lipid particles and nucleic acid delivery carrier
#4759Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
#4760Method for expression of small RNA molecules within a cell
#4761Reduction of TGFβ signaling in myeloid cells in the treatment of cancer
#4762Serpina1 iRNA compositions and methods of use thereof
#4763POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS
#4764RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#4765Use of negative functional modulators of erythropoietin for therapy
#4766SLIT-ROBO-Myo9-RHOA PATHWAY AND CANCER
#4767Ionizable cationic lipid for RNA delivery
#4768Delivery of hydrophobic active agent particles
#4769VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER
#4770CELL DELIVERY SYSTEM AND METHOD
#4771All sterile males of culicine mosquitoes: a method of creation
#4772COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA
#4773Pharmaceutical composition for treating chronic kidney disease
#4774Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#4775Monomers and oligonucleotides comprising cycloaddition adduct(s)
#4776Oligonucleotide end caps
#4777Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
#4778Transmission blocking vaccines for mosquito-borne
#4779STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#4780Methods For Treating Nicotinic Acetylcholine Receptor Associated Diseases
#4781Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) autosomal dominant osteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation
#4782METHODS OF INHIBITING VIRAL REPLICATION COMPRISING THE SIGNAL PEPTIDASE COMPLEX
#4783Modulation of gene expression and screening for deregulated protein expression
#4784Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#4785RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF CKAP5 GENE
#4786Compounds and methods for trans-membrane delivery of molecules
#4787Lipocationic polymers and uses thereof
#4788Genomic instability markers in Fanconi anemia
#4789Use of CPNE7 for differentiating non-dental mesenchymal stem cells into odontoblasts, regenerating dental pulp and treating dentin hypersensitivity
#4790PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#4791INHIBITING GENE EXPRESSION WITH dsRNA
#4792Compositions and methods for inhibiting gene expression of LPA
#4793siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#4794Diblock copolymers and polynucleotide complexes thereof for delivery into cells
#4795AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER
#4796Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling
#4797Compositions and methods for controlling arthropod parasite and pest infestations
#4798Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
#4799METHODS FOR TREATING AND PREVENTING ALLERGIES AND ACUTE ALLERGIC RESPONSES
#4800Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy